Search - tctmd.com

Displaying 661 - 680 of 709

Sort: Relevancy | Date

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Industry News

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

November 10, 2011

News Industry News

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

November 09, 2011

News Industry News

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

November 08, 2011

News Industry News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

News Conference News

DES and Stent Thrombosis Revisited

November 07, 2011

News Conference News

Evidence of Late Catch-up After DES ‘Unequivocal’

November 06, 2011

News Industry News

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

November 04, 2011

News Daily News

DES Associated with Less Downstream Lesion Development than BMS

L.A. McKeown

November 04, 2011

News Industry News

Micell Technologies Announces Presentation of Clinical Data at TCT 2011

November 02, 2011

News Industry News

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

November 02, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Industry News

IVUS Cohort Recruitment Complete in Landmark Tryton IDE Study

October 26, 2011

News Daily News

FFR Guides Therapy for Proximal LAD Lesions

Jason Kahn

October 26, 2011

News Daily News

DISCOVER-FLOW Published: Noninvasive FFR Shows High Diagnostic Accuracy

Leah Lawrence

October 24, 2011

News Daily News

IVUS Guidance of DES Implantation Improves Outcomes

September 28, 2011

News Industry News

Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN

September 27, 2011

News Daily News

Virtual Histology IVUS Links Vulnerable Plaque to Future Events

August 17, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

IVUS Criterion a Safe Guide to Deferral of Left Main Intervention

July 11, 2011

Advertisement

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

DES and Stent Thrombosis Revisited

Evidence of Late Catch-up After DES ‘Unequivocal’

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

DES Associated with Less Downstream Lesion Development than BMS

Micell Technologies Announces Presentation of Clinical Data at TCT 2011

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

IVUS Cohort Recruitment Complete in Landmark Tryton IDE Study

FFR Guides Therapy for Proximal LAD Lesions

DISCOVER-FLOW Published: Noninvasive FFR Shows High Diagnostic Accuracy

IVUS Guidance of DES Implantation Improves Outcomes

Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN

Virtual Histology IVUS Links Vulnerable Plaque to Future Events

Women Have Less Neointimal Hyperplasia Than Men With ZES

IVUS Criterion a Safe Guide to Deferral of Left Main Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content